Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 2
2005 3
2007 1
2009 4
2010 1
2011 1
2012 3
2013 2
2014 2
2015 2
2016 2
2017 2
2018 1
2019 2
2020 2
2021 4
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Inhibitors of kallikrein-related peptidases: An overview.
Masurier N, Arama DP, El Amri C, Lisowski V. Masurier N, et al. Among authors: lisowski v. Med Res Rev. 2018 Mar;38(2):655-683. doi: 10.1002/med.21451. Epub 2017 Jun 13. Med Res Rev. 2018. PMID: 28609548 Review.
4-Substituted Thieno[3,2-d]pyrimidines as Dual-Stage Antiplasmodial Derivatives.
Lagardère P, Mustière R, Amanzougaghene N, Hutter S, Franetich JF, Azas N, Vanelle P, Verhaeghe P, Primas N, Mazier D, Masurier N, Lisowski V. Lagardère P, et al. Among authors: lisowski v. Pharmaceuticals (Basel). 2022 Jul 1;15(7):820. doi: 10.3390/ph15070820. Pharmaceuticals (Basel). 2022. PMID: 35890119 Free PMC article.
Synthetic therapeutic peptides: science and market.
Vlieghe P, Lisowski V, Martinez J, Khrestchatisky M. Vlieghe P, et al. Among authors: lisowski v. Drug Discov Today. 2010 Jan;15(1-2):40-56. doi: 10.1016/j.drudis.2009.10.009. Epub 2009 Oct 30. Drug Discov Today. 2010. PMID: 19879957 Review.
New antiplasmodial 4-amino-thieno[3,2-d]pyrimidines with improved intestinal permeability and microsomal stability.
Lagardère P, Mustière R, Amanzougaghene N, Hutter S, Casanova M, Franetich JF, Tajeri S, Malzert-Fréon A, Corvaisier S, Azas N, Vanelle P, Verhaeghe P, Primas N, Mazier D, Masurier N, Lisowski V. Lagardère P, et al. Among authors: lisowski v. Eur J Med Chem. 2023 Mar 5;249:115115. doi: 10.1016/j.ejmech.2023.115115. Epub 2023 Jan 13. Eur J Med Chem. 2023. PMID: 36680984
Synthesis of antiplasmodial 2-aminothieno[3,2-d]pyrimidin-4(3H)-one analogues using the scaffold hopping strategy.
Mustière R, Lagardère P, Hutter S, Dell'Orco V, Amanzougaghene N, Tajeri S, Franetich JF, Corvaisier S, Since M, Malzert-Fréon A, Masurier N, Lisowski V, Verhaeghe P, Mazier D, Azas N, Vanelle P, Primas N. Mustière R, et al. Among authors: lisowski v. Eur J Med Chem. 2022 Nov 5;241:114619. doi: 10.1016/j.ejmech.2022.114619. Epub 2022 Jul 20. Eur J Med Chem. 2022. PMID: 35872545
Pd-catalyzed C-C and C-N cross-coupling reactions in 2-aminothieno[3,2-d]pyrimidin-4(3H)-one series for antiplasmodial pharmacomodulation.
Mustière R, Lagardère P, Hutter S, Deraeve C, Schwalen F, Amrane D, Masurier N, Azas N, Lisowski V, Verhaeghe P, Mazier D, Vanelle P, Primas N. Mustière R, et al. Among authors: lisowski v. RSC Adv. 2022 Jul 8;12(31):20004-20021. doi: 10.1039/d2ra01687g. eCollection 2022 Jul 6. RSC Adv. 2022. PMID: 35865200 Free PMC article.
38 results